
Developing a cost-effective imaging strategy, fully integrated into a broader clinical development process, requires specific knowledge of regulatory requirements and ever-changing industry trends. Our consulting services are lead by a team with over 25 combined years experience in the use of medical imaging in clinical trials. Additional world-class imaging consulting expertise is available through the worldwide RadMD network of over 600 physicians and imaging medical physicists.
When independent image evaluations (“blinded reads”) are used in trials, it is critical that physicians performing the evaluations have expertise in the disease process. Our blinded reader sourcing service matches the most qualified physicians to individual studies, with the largest global network of physicians who have undergone standardized training as blinded readers. This translates into faster image evaluations by the most qualified personnel for your trials.
When independent image evaluations (“blinded reads”) are used in trials, it is critical that physicians performing the evaluations have expertise in the disease process. Our blinded reader sourcing service matches the most qualified physicians to individual studies, with the largest global network of physicians who have undergone standardized training as blinded readers. This translates into faster image evaluations by the most qualified personnel for your trials.

JULY 22, 2010
Dr. Patt presents "Site & Central Reads in Oncology Trials: Controversies and Risk Management Strategies"
JULY 22, 2010
RadMD attends Joint FDA-MIPS Workshop on Methods for the Evaluation of Imaging and Computer-Assist Devices:
July 14, 2010: Rockville, MD
July 14, 2010: Rockville, MD
MAY 05, 2010
RadMD to Attend:
ASCO June 4-8 2010, Chicago, IL
DIA June 13-17 2010; Washington, DC
ASCO June 4-8 2010, Chicago, IL
DIA June 13-17 2010; Washington, DC

